Form 8-K - Current report:
SEC Accession No. 0001213900-24-099837
Filing Date
2024-11-19
Accepted
2024-11-19 08:10:08
Documents
14
Period of Report
2024-11-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0221755-8k_regenerative.htm   iXBRL 8-K 23196
2 PRESS RELEASE, DATED NOVEMBER 19, 2024 ea022175501ex99-1_regener.htm EX-99.1 10021
  Complete submission text file 0001213900-24-099837.txt   203806

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rmtg-20241119.xsd EX-101.SCH 3042
4 XBRL LABEL FILE rmtg-20241119_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE rmtg-20241119_pre.xml EX-101.PRE 22377
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0221755-8k_regenerative_htm.xml XML 3255
Mailing Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432
Business Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432 800-889-9509
Regenerative Medical Technology Group Inc. (Filer) CIK: 0001760026 (see all company filings)

EIN.: 880492191 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56010 | Film No.: 241473408
SIC: 5990 Retail-Retail Stores, NEC
(CF Office: 07 Trade & Services)